Results 191 to 200 of about 3,080,927 (317)

Defining high-risk pregnancy: Protocol for a systematic scoping review of clinical determinants, complications, and adverse birth outcomes. [PDF]

PLoS One
Yang X, Chen XW, Baker PRA.
europepmc   +1 more source

Improved matrix and determinant methods for solving networks [PDF]

, 1955
H. Orchard
openalex   +1 more source

Determinism [PDF]

The Behavior Analyst, 1982
openaire   +2 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Correction: Level and determinants of pentavalent vaccine dropout during infancy: A hierarchical analysis of community-level longitudinal study. [PDF]

PLoS One
Bekuma TT, Seme A, Ahmed S, Abera M.
europepmc   +1 more source

XXV.—The Generating Function of the Reciprocal of a Determinant [PDF]

, 1905
Thomas Muir
openalex   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

NOTE ON AN OVERLOOKED THEOREM REGARDING THE PRODUCT OF TWO DETERMINANTS OF DIFFERENT ORDERS [PDF]

, 1913
Thomas Muir
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Note on a Simple Graphic Illustration of the Determinantal Relation of Dynamics [PDF]

, 1894
G. H. Bryan
openalex   +1 more source